arGentis Pharmaceuticals' Unattributed VC Round

arGentis Pharmaceuticals raised a round of funding on April 14, 2008. Investors include Innova Memphis.

arGentis Pharmaceuticals is a diversified specialty biopharmaceutical company seeking to license and commercialize therapies with demonstrated proof of concept for chronic diseases.…

Articles about arGentis Pharmaceuticals' Unattributed VC Round: